Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

*Product:*	Erlyand
Active Ingredient:	Apalutamide 60mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Janssen-Cilag (New Zealand) Limited
Manufacturers:	Catalent Pharma Solutions LLC, Kentucky, United States of America Janssen Ortho LLC, Gurabo, Puerto Rico

*Product:*	Ritemvia (100mg/10mL)
Active Ingredient:	Rituximab 10mg/mL
Dosage Form:	Concentrate for infusion
New Zealand Sponsor:	Celltrion Healthcare New Zealand Limited
Manufacturers:	Simtra Deutschland GmbH, Halle, Germany Celltrion Inc., Incheon, South Korea

*Product:*	Ritemvia (500mg/50mL)
Active Ingredient:	Rituximab 10mg/mL
Dosage Form:	Concentrate for infusion
New Zealand Sponsor:	Celltrion Healthcare New Zealand Limited
Manufacturers:	Simtra Deutschland GmbH, Halle, Germany Celltrion Inc., Incheon, South Korea

*Product:*	Truxima (100mg/10mL)
Active Ingredient:	Rituximab 10mg/mL
Dosage Form:	Concentrate for infusion
New Zealand Sponsor:	Celltrion Healthcare New Zealand Limited
Manufacturers:	Simtra Deutschland GmbH, Halle, Germany Celltrion Inc., Incheon, South Korea

*Product:*	Truxima (500mg/50mL)
Active Ingredient:	Rituximab 10mg/mL
Dosage Form:	Concentrate for infusion
New Zealand Sponsor:	Celltrion Healthcare New Zealand Limited
Manufacturers:	Simtra Deutschland GmbH, Halle, Germany Celltrion Inc., Incheon, South Korea

Dated this 15th day of June 2026.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule